If you've already registered, please click here to log in to the webcast
After decades of lab research, gene editing has emerged as one of the most promising tools in clinical development. More than just therapies, gene editing could enable actual cures for diseases that include cancer and HIV. So, what will it take to realize this promise, and what has yet to be accomplished?
In this virtual event, hosted by Scientific American Custom Media, luminaries in the field will reflect on gene editing’s early days and explore the innovation landscape as a whole, with a focus on developing therapeutics, new disease targets and potential challenges to progress.
Please join us to learn from some of the most brilliant minds in this rapidly growing area of medicine. A brief audience Q&A will follow the panel.
This event is produced in partnership with Cellectis